Journal of Endocrinological Investigation

, Volume 32, Issue 2, pp 102–106 | Cite as

Thyrotropin levels and their relationship with cardiovascular risk factors in the island of Gran Canaria, Spain. Implications of lowering the upper reference limit of thyrotropin stimulating hormone

  • M. Alberiche
  • M. Boronat
  • P. Saavedra
  • N. Pérez
  • D. Marrero
  • Y. López-Plasencia
  • V. F. Varillas
  • M. Ríos
  • F. J. Nóvoa
Original Articles


Objective: To characterize the cardiovascular risk profile of subjects with high and normal-high concentrations of serum TSH in a sample of adult Spanish subjects from the island of Gran Canaria. Design: Cross-sectional population-based study. Subjects: After excluding 28 individuals on current treatment with levothyroxine and 9 others with TSH levels below the range of normality (0.3–4.9 mU/l), 704 randomly selected subjects (412 women; age range: 30–82 yr) belonging to the Telde Study were assessed. Measurements: Participants underwent physical examination and fasting blood analyses to determinate TSH, serum lipids, homocysteine, fibrinogen, von Willebrand factor, plasminogen activator inhibitor-1, C-reactive protein, and insulin. Results: Twenty-nine participants had serum TSH concentrations above the normal range of normality. Among all the studied variables, only female sex and diastolic blood pressure were significantly associated with TSH levels >-5 mU/l in a multivariate logistic regression analysis. If the upper normal limit of TSH was reduced up to 2.4 mU/l, an additional group of 106 subjects would be considered to have elevated TSH levels. A serum TSH>-2.5 mU/l was positive and independently associated with female sex, body mass index, total cholesterol, and homocysteine, and negatively associated with smoking. Conclusions: Although the impact of serum TSH levels on cardiovascular risk cannot be established from these findings, TSH values within the upper part of the usually accepted normal range were demonstrated to be associated with well-recognized risk factors for cardiovascular disease.


Cardiovascular risk factors TSH 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000, 160: 526–34.PubMedCrossRefGoogle Scholar
  2. 2.
    Hollowell J, Staehling N, Flanders D, et al. Serum TSH, T4 and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002, 87: 489–99.PubMedCrossRefGoogle Scholar
  3. 3.
    Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk and mortality in older adults. JAMA 2006, 295: 1033–41.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Rodondi N, Newman AB, Vittinghoff E, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 2005, 165: 2460–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Walsh JP, Bremmer AP, Bulsara MK, et al. Subclinical thyroid dysfunction as a risk for cardiovascular disease. Arch Intern Med 2005, 165: 2467–72.PubMedCrossRefGoogle Scholar
  6. 6.
    Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004, 291: 228–38.PubMedCrossRefGoogle Scholar
  7. 7.
    Waterhouse DF, McLaughlin AM, Walsh CD, Sheehan F, O’Shea D. An examination of the relationship between normal range thyrotropin and cardiovascular risk parameters: a study in healthy women. Thyroid 2007, 17: 243–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Roos A, Bakker S, Links T, Gans R, Wolffenbuttel B. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab 2007, 92: 491–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Boronat M, Varillas VF, Saavedra P, et al. Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain): prevalence and associated factors in the adult population of Telde, Gran Canaria. Diabet Med 2006, 23: 148–55.PubMedCrossRefGoogle Scholar
  10. 10.
    Nóvoa FJ, Boronat M, Saavedra P, et al. Differences in cardiovascular risk factors, insulin resistance and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation. Diabetes Care 2005, 28: 2388–93.PubMedCrossRefGoogle Scholar
  11. 11.
    Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Dunn JT, Crutchfield HE, Gutekunst R, Dunn AD. Two simple methods for measuring iodine in urine. Thyroid 1993, 3: 119–23.PubMedCrossRefGoogle Scholar
  13. 13.
    Baloch Z, Carayon P, Conte-Devolx B, et al; Guidelines Committee, National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003, 13: 3–126.PubMedCrossRefGoogle Scholar
  14. 14.
    World Health Organization Department of Non Communicable Disease Surveillance. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO Consultation. 1999 Geneva, World Health Organisation, (WHO/NCD/NCS/99.2).Google Scholar
  15. 15.
    Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109: 433–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Díez JJ, Molina I, Ibars MT. Prevalence of thyroid dysfunction in adults over age 60 years from an urban community. Exp Clin Endocrinol Diabetes 2003, 11: 480–5.Google Scholar
  17. 17.
    Sender Palacios MJ, Vernet Vernet M, Pérez López S, Faro Colomés M, Rojas Blanc M, Pallisa Gabriel L. Functional thyroid pathology in the elderly. Aten Primaria 2004, 34: 192–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Ania Lafuente BJ, Suárez Almenara JL, Fernández-Burriel Tercero M, Gueraa Hernández L, Betancort Mastrángelo C. Thyroid function in the aged admitted to a nursing home. An Med Interna 2000, 17: 5–8.PubMedGoogle Scholar
  19. 19.
    Betancor E, Aguado R, Gómez-Carracedo A, Baztán JJ. Prevalence of thyroid dysfunction in hospitalized older persons. Med Clin (Barc) 2004, 123: 77–8.CrossRefGoogle Scholar
  20. 20.
    Hoogendoorn EH, Hermus AR, de Vegt F, et al. Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem 2006, 52: 104–11.PubMedCrossRefGoogle Scholar
  21. 21.
    Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and anthtyroid antibodies in the US population: Implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 2007, 92: 4575–82.PubMedCrossRefGoogle Scholar
  22. 22.
    Nyrnes A, Jorde R, Sundsfjord J. Serum TSH is positively associated with BMI. Int J Obesity (Lond) 2006, 30: 100–5.CrossRefGoogle Scholar
  23. 23.
    Knudsen N, Laurberg P, Rasmussen LB, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 2005, 90: 4019–24.PubMedCrossRefGoogle Scholar
  24. 24.
    Åsvold BO, Vatten LJ, Nilsen TIL, Bjøro T. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol 2007, 156: 181–6.CrossRefGoogle Scholar
  25. 25.
    Michalopoulou G, Alevizaki M, Piperingos G, et al. High serum cholesterol levels in persons with ‘high-normal’ TSH levels: should one extend the definition of subclinical hypothyroidism? Eur J Endocrinol 1998, 138: 141–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Tunbridge WM, Evered DC, Hall R, et al. Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol (Oxf) 1977, 7: 495–508.CrossRefGoogle Scholar
  27. 27.
    Hueston WJ, Pearson WS. Subclinical hypothyroidism and the risk of hypercholesterolemia. Ann Fam Med 2004, 2: 351–5.PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Walsh JP, Bremner AP, Bulsara MK, et al. Thyroid dysfunction and serum lipids: a community-based study. Clin Endocrinol (Oxf) 2005, 63: 670–5.CrossRefGoogle Scholar
  29. 29.
    Morris MS, Bostom AG, Jacques PF, Selhub J, Rosenberg IH. Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey. Atherosclerosis 2001, 155: 195–200.PubMedCrossRefGoogle Scholar
  30. 30.
    Lindeman RD, Romero LJ, Schade DS, Wayne S, Baumgartner RN, Garry PJ. Impact of subclinical hypothyroidism on serum total homocysteine concentrations, the prevalence of coronary heart disease (CHD), and CHD risk factors in the New Mexico Elder Health Survey. Thyroid 2003, 13: 595–600.PubMedCrossRefGoogle Scholar
  31. 31.
    Hueston WJ, King DE, Geesey ME. Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism. Clin Endocrinol (Oxf) 2005, 63: 582–7.CrossRefGoogle Scholar
  32. 32.
    Cantürk Z, Cetinarslan B, Tarkun I, Cantürk NZ, Ozden M, Duman C. Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 2003, 13: 971–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Belin RM, Astor BC, Powe NR, Ladenson PW. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2004, 89: 6077–86.PubMedCrossRefGoogle Scholar
  34. 34.
    Asvold BO, Bjøro T, Nilsen TIL, Vatten LJ. Tobacco smoking and thyroid function: a population-based study. Arch Intern Med 2007, 167: 1428–32.PubMedCrossRefGoogle Scholar
  35. 35.
    Saito I, Ito K, Saruta T. Hypothyroidism as a cause of hypertension. Hypertension 1983, 5: 112–5.PubMedCrossRefGoogle Scholar
  36. 36.
    Walsh JP, Bremner AP, Bulsara MK, et al. Subclinical thyroid dysfunction and blood pressure: a community-based study. Clin Endocrinol (Oxf) 2006, 65: 486–91.CrossRefGoogle Scholar
  37. 37.
    Iqbal A, Figenschan Y, Jorde R. Blood pressure in relation to serum thyrotropin: the Tromsø Study. J Hum Hypertens 2006, 20: 932–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Asvold BO, Bjoro T, Nilsen TJ, Vatten LJ. Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study. J Clin Endocrinol Metab 2007, 92: 841–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Luboshitzky R, Aviv A, Herer P, Lavie L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 2002, 12: 421–5.PubMedCrossRefGoogle Scholar
  40. 40.
    Nagasaki T, Inaba M, Kumeda Y, et al. Increased pulse wave velocity in subclinical hypothyroidism. J Clin Endocrinol Metab 2006, 91: 154–8.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2009

Authors and Affiliations

  • M. Alberiche
    • 1
  • M. Boronat
    • 1
  • P. Saavedra
    • 2
  • N. Pérez
    • 1
  • D. Marrero
    • 1
  • Y. López-Plasencia
    • 1
  • V. F. Varillas
    • 3
  • M. Ríos
    • 4
  • F. J. Nóvoa
    • 1
  1. 1.Section of Endocrinology and NutritionInsular University HospitalSpain
  2. 2.Mathematics DepartmentUniversity of Las PalmasLas Palmas de Gran Canaria
  3. 3.Service of Internal MedicineGeneral Hospital of FuerteventuraLas Palmas
  4. 4.Endocrinology Investigation LaboratoryCies General HospitalVigoSpain

Personalised recommendations